2016
$9.3M
from 7 investors over 7 rounds
Regenacy Pharmaceuticals, Inc. raised $9.3M on August 15, 2022
Investors: Taiwania Capital, COBRO VENTURES, INC and 3E Bioventures Capital
Regenacy Pharmaceuticals, Inc. raised undisclosed on March 25, 2020
Investors: Taiwania Capital, 3E Bioventures Capital, COBRO VENTURES, INC and Viva Biotech (Shanghai) Ltd.